Remove 2019 Remove License Remove Portfolio
article thumbnail

Titagarh Railsystems vs Jupiter Wagons – Future Plans & More

Trade Brains

2019-20 ₹ 1,766.32 ₹ 125.74 2019-20 ₹ - 36.14 -₹ 0.13 Particulars/ Financial Year RoCE (%) Titagarh Railsystems Jupiter Wagons 2022-23 16.82% 23.88% 2021-22 8.87% 11.74% 2020-21 4.27% 11.24% 2019-20 1.87% 2.36% 2018-19 1.08% 1.06% Debt Analysis Titagarh and Jupiter’s debt-to-equity ratios in FY23 were 0.71 2019-20 0.36 -0.48

Planning 105
article thumbnail

Fundamental Analysis of Bajaj Consumer Care – Financials & More

Trade Brains

The company turned into a subsidiary of Bajaj Resources in 2008, licensing its brand to itself. In 2019, the company renamed itself to what we know today – Bajaj Consumer Care. In CR) FY 2019 918 30.9% Return Ratios Financial Year ROE ROCE FY 2019 47.41 221 FY 2020 852 26.8% 184 FY 2021 921 29.4% FY 2020 28.28

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Fundamental Analysis of Ujjivan Small Finance Bank

Trade Brains

It is licensed under the Banking Regulation Act, to carry out small finance bank business. Fiscal Year Net Interest Income Net Profit / Loss 2023 2698 1100 2022 1774 -415 2021 1729 8 2020 1634 350 2019 1107 199 5 Year CAGR 24.95% 53.29% Deposits & Advances Deposits of the Bank have been growing by 36.39% on a 5-year CAGR basis.

Banking 126
article thumbnail

Fundamental Analysis of Exide Industries – Future Plans & More

Trade Brains

2019 14720.88 Fiscal Year Operating Margin Net Margin 2023 10.57% 5.46% 2022 10.97% 5.43% 2021 13.19% 7.08% 2020 9.82% 5.27% 2019 10.39% 5.76% 5 Year Average 10.99% 5.80% Return Ratios The Company’s Return on Capital Employed has been on a falling spree. However, its 5-year CAGR shows a de-growth of 0.68%. 2022 12789.22 2021 10359.43

Planning 119
article thumbnail

10 Best Bond Brokers in India All You Need To Know!

Trade Brains

Early investors typically take more risks at the start of their careers or in their early and late 20s, and as they age, they diversify their portfolio by shifting away from equities and towards fixed-income securities such as bonds and debentures, which carry little or no risk based on the securities purchased and are based on yield return.

article thumbnail

Cipla Vs Dr. Reddy’s Laboratories – Financials, Future Plans & More

Trade Brains

Following global demand, Cipla has deepened its portfolio for the US markets with continued traction in the respiratory franchise and expansion of its peptide portfolio with increased market share in the Company’s first Lanreotide injection. This portfolio is boosted by the successful launch of gRevlimid. respectively.

article thumbnail

NMDC Vs GMDC – Financials, Future Plans & More

Trade Brains

After years of restrictions, the Indian government is considering granting licenses to the private sector. Particulars/ Financial Year 2018-19 2019-20 2020-21 2021-22 2022-23 CAGR (%) NMDC - Revenue (Cr.) ₹ 12,152.67 ₹ 11,699.22 ₹ 15,370.06 ₹ 25,964.79 ₹ 17,666.88 crore and Rs. crore, respectively, with a CAGR of 4.54% and 53.33%.